9/20/2018CDE Seeks Comments on Draft Chinese Translations of Seven ICH Guidelin...

9/20/2018China Medical System Signs License and Partnership Deal with VAXIMM AG

9/20/2018Should You Look At China For Your Next Clinical Trial?

9/20/2018Wuxi AppTech Submitted $1B+ IPO Application in Hong Kong

9/19/2018State Council Introduces New Policy to Improve the National Essential ...

9/19/2018Merck Slashes Price of Anticancer Keytruda for China Launch

9/19/2018Lilly China and Microsoft Enter Digital Health Partnership Using AI to...

9/18/2018CBT Pharma Initiates the APOLLO Oncology Clinical Trials Program

9/18/2018Top 25 Global Pharmaceutical Companies by Market Cap 2018

9/18/2018R&D Cooperation Between China and Western Pharma Companies Up 70%

9/17/2018NHC Issues the Provisions for Clinical Application of Medical Technolo...

9/17/2018NHC Issues Three New Rules to Guide and Regulate Development of Intern...

9/14/2018Recent Official and Executive Movements

9/14/2018EpimAb Announces IND Filing for EMB01 in China and the US

9/14/2018Chinese Drug-releasing Heart Stent Clears Clinical Trials in Europe

9/14/2018Can A Cancer Drug Originated In China Be A Success In The U.S.?

9/14/2018Takeda Wins Chinese Approval of Its $62B Shire Acquisition Deal

9/13/2018EU Regulators Issue Notice on a Chinese Anticancer API After Rejected ...

9/13/2018Athenex and Hanmi Pharma Realign Their Joint Projects

9/13/2018Allergan and AliHealth to Launch Digital Platform for Medical Aestheti...

9/11/2018SMIA’s Official Responsibilities and Internal Organization Approved

9/11/2018NMPA's Official Responsibilities and Internal Organization Approved

9/11/2018SAMR's Official Responsibilities and Internal Organization Approved

9/11/2018WuXi Biologics and Inhibrx Enter an Exclusive Partnership for GMP Manu...

9/11/2018Innovent Receives Chinese IND Approval for mAb Drug Candidate

9/11/2018China CDMO Market 2018-2021: The R&D Cost of New Drugs Continues t...

9/10/2018NMPA Issues New Announcement (2018#64) for Clinical Data Self-Inspecti...

9/7/2018Recent Executive Moves

9/7/2018Nearly 90% of Listed Biopharma Cos Saw their Sales Expenditures Up in ...

9/7/2018Astellas Launches Its OAB Drug Myrbetriq (mirabegron) in China

Page:132/334 Total number of articles:9998: [First][<<] [130] [131] [132] [133] [134] [>>] [End]